Intravenous Immune Globulin for Statin-Triggered Autoimmune Myopathy
Authors:
- Andrew L. MammenAMAndrew L. Mammen
- Eleni TiniakouETEleni Tiniakou
- 22 October 2015
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 373 (17) , 1680-1682
Abstract
Although most statin-related myopathy is self-limited, in rare cases statins trigger autoimmune myopathy, which requires control with immunosuppressive therapy. Three patients with this disorder were treated with intravenous immunoglobulin as initial therapy, with some benefit.Keywords
This publication has 5 references indexed in Scilit:
- Anti-HMGCR Autoantibodies in European Patients With Autoimmune Necrotizing MyopathiesMedicine, 2014
- Antibody levels correlate with creatine kinase levels and strength in anti–3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase–associated autoimmune myopathyArthritis & Rheumatism, 2012
- Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathyArthritis & Rheumatism, 2010
- Immune‐mediated necrotizing myopathy associated with statinsMuscle & Nerve, 2009
- Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and ImmunologyJournal of Allergy and Clinical Immunology, 2006